Gujarat Terce Laboratories Limited · BSE:GUJTERC
Gujarat Terce Laboratories — Q2 FY2022 Earnings Presentation
10 slides from Gujarat Terce Laboratories's earnings presentation, October 2021
Slide 1: Gujarat Terce Laboratories Quarter 2 FY 22
GUJARAT TERCE f= LABORATORIES LIMITED Roa) aaiOn aN NG 4 __ Quarter 2 FY 22 (September- 2021)
Slide 2: Disclaimer
Disclaimer This presentation is for informational purposes only and does not constitute an offer or a solicitation to sell or a edition or a solicitation to submit an offer to purchase or subscribe for shares or securities of Gujarat Terce Laboratories Ltd.Or a portion thereof , constitute the Basis
Slide 3: 1. Company Overview 2. CEO's Message 3. Business Highlights
1. Company Overview 2. CEO's Message 3. Business Highlights 4. Financial Highlights Page:3
Slide 4: Company Overview
Company Overview Established in the Listed on BSE in the Started manufacturing plant in the Started Exports in the year 1985 year 1992 year 1992 year 2005 DAVIS THORNE AND PARTNERS Since 1999 Network of Presence in 180+ products in Presence in 25000+ doctors 13 states of India 10 Therapeutic areas 2
Slide 5: CEO's Message
CEO's Message Dear Shareholders, Gujarat Terce has seen a strong revenue growth of 64.74 % YonY and a PAT growth of 547.32 % YonY on half yearly basis. The growth is driven through a combination of low base, organic demand in Acute portfolio, and focused growth in chronic portfolio & Top brands. The
Slide 6: Business Highlights
Business Highlights 100 Figures= % of total sales Figures= % of total sales 76.1 80.82 83.00 81.00 Q1FY21 23.9 79 75 Acute Segment 75 Other Brands Q2FY21 25 TOP Brands Chronic Segment 50 64.1 25 Q1FY22 19.18 17.00 19.00 21.00 35.9 62.8 Q2FY22 37.2 0 Q1FY21 Q2FY21 Q1FY22 Q2FY22 0 20 40 60 80 Total Sa
Slide 7: Business Highlights- PCPM (Per Capita Per Month)
Business Highlights- PCPM (Per Capita Per Month) Figures in lacs 2 1.92 1.87 1.5 1.29 1.05 1 0.5 0 Q3FY21 Q4FY21 Q1FY22 Q2FY22 Per Capita per month Sales in lacs Page:7
Slide 8: Financial Highlights- Revenue
Financial Highlights- Revenue Figures in lacs 3,000 2598 2,000 2020 Revenue growth in H1FY 22 is 64 % YonY 1233 PAT growth in H1FY22 is 547.32% YonY 1000 1020 1,000 0 H1 FY 21 FY 21 Q1 FY 22 Q2 FY 22 H1 FY 22 Page:8
Slide 9: Q2 FY 22- Income Statement
Q2 FY 22- INCOME STATEMENT Key highlights of Q2 FY 21 vs Q1 FY 21 (QonQ Growth) Operating Revenue growth of 2% vs Q1 FY 22 Consistent performance in Q1 and Q2 in FY 22 in line with our projected revenue of FY 22 Page:9
Slide 10: Thank you.
Thank you. Registered Office: Gujarat Terce Laboratories Limited, 122/3 Ravi estate, Bileshwarpura, Chhatral, T.A.: Kalol, Gandhinagar, Gujarat 382729 Corporate office: D/ 801 - 802 & 1202, The First, Behind Keshavbaug party plot, Near Shivalik High- Street, Vastrapur, Ahmedabad, Gujarat 380015 Inve
Gujarat Terce Laboratories — Q2 FY2022 Earnings Presentation on 6ix